HOME >> BIOLOGY >> NEWS
Vaccines against foodborne disease on horizon

NEW ORLEANS May 24, 2004 -- Researchers are making promising steps towards the development of a number of vaccines against foodborne disease, according to several studies released today at the 104th General Meeting of the American Society for Microbiology.

"Vaccines have been proven to be an effective means of prevention for many infectious diseases, but there are no effective vaccines for most common foodborne diseases," says John Gunn of the Ohio State University who presents research on a new vaccine against multiple bacteria. "The development of a single vaccine that provides protection against the most common foodborne pathogens would greatly enhance human health and well-being worldwide."

Gunn and his colleagues have developed a strategy using a live, crippled strain of Salmonella bacteria that do not cause disease and outfit it with "pieces" of other bacterial pathogens to stimulate immunity to multiple pathogens.

"We have already developed a highly attenuated Salmonella typhimurium strain which functions as an effective live, oral vaccine against S. typhimurium," says Gunn.

The researchers modified the vaccine strain so that it also contains a gene from another foodborne pathogen, Listeria monocytogenes. When they administered the modified oral vaccine to mice, it protected them 100 percent against lethal doses of both foodborne bacteria.

Another group of researchers at the meeting today announced they were one step closer toward the development of an edible vaccine against the most virulent forms of the Escherichia coli bacteria, known as shiga toxin-producing E. coli, which include the destructive E. coli O157:H7. These bacteria, because of the shiga toxin they produce, can cause mild to bloody diarrhea and in some cases are responsible for a complication known as hemolytic uremic syndrome, which is characterized by kidney failure, brain damage and sometimes death.

Sharon Wen and her colleagues at
'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
24-May-2004


Page: 1 2

Related biology news :

1. Bacteria Becoming Increasingly Resistant To Antibiotics, But New Vaccines Are On The Horizon
2. Colorado State Research Indicates Two TB Vaccines Show Promise
3. New Company To Turn UNC-CH, Army Inventions Into Improved Vaccines
4. New Vaccine Blocks Viral Entry In Cattle, May Have Implications For Human Vaccines
5. Certain genes boost fish oils protection against breast cancer
6. New research suggests early diet may play key role in protecting against childhood leukaemia
7. $18 million bioinformatics center to become weapon against deadly diseases
8. Bodys own defense against H. pylori, cause of stomach ulcers and stomach cancer
9. Molecular therapeutics advance fight against brain cancer
10. Smart gene therapy protects against damage from heart attack
11. HIV reveals evolution of a primate defense against intragenomic infiltrators

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/13/2020)... ... March 13, 2020 , ... Acumed LLC today announced ... exclusive distributor of the Louisville-based company’s orthobiologics portfolio. Under the terms of the ... Vivorte’s calcium phosphate-based bone allograft (Trabexus) and calcium phosphate-based biocement (Fortera). Vivorte will ...
(Date:3/9/2020)... ... March 09, 2020 , ... ... a steep growth rate of 64% last year, as enterprises sought to ... from Everest Group. Unfortunately, only 13% of all transformation efforts delivered the ...
(Date:3/5/2020)... ... 2020 , ... Diagenode, a leading global provider of complete ... of global genomics leader BGI Group, today announced a co-marketing agreement for Diagenode’s ... Pacific. , Under the terms of the non-exclusive agreement, the two companies ...
Breaking Biology News(10 mins):
(Date:3/19/2020)... ... March 17, 2020 , ... ... collaboration agreement with pioneering gene circuit company Senti Biosciences, Inc. (Senti) to ... and other solid tumor indications. The collaboration will leverage RoosterBio’s human mesenchymal ...
(Date:3/10/2020)... Tex. (PRWEB) , ... March ... ... a full-service cold chain biopharmaceutical engineering firm, is pleased to announce ... focus is on combination medical device qualification and validation in the biopharmaceutical ...
(Date:3/3/2020)... ... 2020 , ... Ideal Implant Incorporated Founder and CEO, Robert ... the IMCAS Innovation Shark Tank 2020 in Paris, France in January. The international ... science industries that promise to revolutionize medical practices in their fields. , ...
(Date:2/21/2020)... ... February 20, 2020 , ... ... and elegant chemistry. Humans have been increasingly successful in innovating ways to ... rapidly evolving technologies and strategies for modern molecular biology (e.g., gene sequencing, ...
Breaking Biology Technology:
Cached News: